![Randomized Study on the Efficacy of Standard Versus Low Roxadustat Dose for Anemia in Patients on Peritoneal Dialysis - ScienceDirect Randomized Study on the Efficacy of Standard Versus Low Roxadustat Dose for Anemia in Patients on Peritoneal Dialysis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2468024921016156-fx1.jpg)
Randomized Study on the Efficacy of Standard Versus Low Roxadustat Dose for Anemia in Patients on Peritoneal Dialysis - ScienceDirect
![PDF) Roxadustat in treating anemia in dialysis patients (ROAD): protocol and rationale of a multicenter prospective observational cohort study PDF) Roxadustat in treating anemia in dialysis patients (ROAD): protocol and rationale of a multicenter prospective observational cohort study](https://i1.rgstatic.net/publication/348470474_Roxadustat_in_treating_anemia_in_dialysis_patients_ROAD_protocol_and_rationale_of_a_multicenter_prospective_observational_cohort_study/links/60012d2892851c13fe106378/largepreview.png)
PDF) Roxadustat in treating anemia in dialysis patients (ROAD): protocol and rationale of a multicenter prospective observational cohort study
![IJERPH | Free Full-Text | Whether Prolyl Hydroxylase Blocker—Roxadustat—In the Treatment of Anemia in Patients with Chronic Kidney Disease Is the Future? IJERPH | Free Full-Text | Whether Prolyl Hydroxylase Blocker—Roxadustat—In the Treatment of Anemia in Patients with Chronic Kidney Disease Is the Future?](https://www.mdpi.com/ijerph/ijerph-18-01612/article_deploy/html/images/ijerph-18-01612-g001-550.jpg)
IJERPH | Free Full-Text | Whether Prolyl Hydroxylase Blocker—Roxadustat—In the Treatment of Anemia in Patients with Chronic Kidney Disease Is the Future?
![Clinical trial paper that made anemia drug look safer than it is will be retracted – Retraction Watch Clinical trial paper that made anemia drug look safer than it is will be retracted – Retraction Watch](https://i0.wp.com/retractionwatch.com/wp-content/uploads/2021/05/roxadustat.jpeg)
Clinical trial paper that made anemia drug look safer than it is will be retracted – Retraction Watch
![Frontiers | Anemia in Chronic Kidney Disease: From Pathophysiology and Current Treatments, to Future Agents Frontiers | Anemia in Chronic Kidney Disease: From Pathophysiology and Current Treatments, to Future Agents](https://www.frontiersin.org/files/Articles/642296/fmed-08-642296-HTML/image_m/fmed-08-642296-g001.jpg)
Frontiers | Anemia in Chronic Kidney Disease: From Pathophysiology and Current Treatments, to Future Agents
![Safety of Roxadustat Versus Erythropoiesis-Stimulating Agents in Patients with Anemia of Non-dialysis-Dependent or Incident-to-Dialysis Chronic Kidney Disease: Pooled Analysis of Four Phase 3 Studies | springermedizin.de Safety of Roxadustat Versus Erythropoiesis-Stimulating Agents in Patients with Anemia of Non-dialysis-Dependent or Incident-to-Dialysis Chronic Kidney Disease: Pooled Analysis of Four Phase 3 Studies | springermedizin.de](https://media.springernature.com/lw150/springer-static/cover/journal/12325/40/4.jpg?as=jpg)
Safety of Roxadustat Versus Erythropoiesis-Stimulating Agents in Patients with Anemia of Non-dialysis-Dependent or Incident-to-Dialysis Chronic Kidney Disease: Pooled Analysis of Four Phase 3 Studies | springermedizin.de
![Roxadustat for the Maintenance Treatment of Anemia in Patients with End-Stage Kidney Disease on Stable Dialysis: A European Phase 3, Randomized, Open-Label, Active-Controlled Study (PYRENEES) | SpringerLink Roxadustat for the Maintenance Treatment of Anemia in Patients with End-Stage Kidney Disease on Stable Dialysis: A European Phase 3, Randomized, Open-Label, Active-Controlled Study (PYRENEES) | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12325-021-01904-6/MediaObjects/12325_2021_1904_Fig1_HTML.png)
Roxadustat for the Maintenance Treatment of Anemia in Patients with End-Stage Kidney Disease on Stable Dialysis: A European Phase 3, Randomized, Open-Label, Active-Controlled Study (PYRENEES) | SpringerLink
Roxadustat for the treatment of anemia in patients with chronic kidney diseases: a meta-analysis | Aging
![Roxadustat Does Not Affect Platelet Production, Activation, and Thrombosis Formation | Arteriosclerosis, Thrombosis, and Vascular Biology Roxadustat Does Not Affect Platelet Production, Activation, and Thrombosis Formation | Arteriosclerosis, Thrombosis, and Vascular Biology](https://www.ahajournals.org/cms/asset/53be6bbb-26ea-46c9-a2bf-86db9bc18909/atvbaha.121.316495.fig06.jpg)